Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Rob Isbitts

2 Turnaround Defense Stocks Hiding in the ITA ETF Tell a Very Clear Story: The Iran War May Not Be Over

My favorite ETF analysis process tells me the mainstream media is missing the real story with the Iran War.

This 2-ETF Portfolio Protects You From a Stock Market Storm and Teaches You the Most Important Investing Lesson Ever

This 2-ETF Portfolio Protects You From a Stock Market Storm and Teaches You the Most Important Investing Lesson Ever

Here’s the very first thing any newer investor should not just know, but truly understand, consider, and personalize, if they want to be successful.

The SpaceX IPO: Why I Think Next Week, Not Friday, Is the Real Event

The SpaceX IPO: Why I Think Next Week, Not Friday, Is the Real Event

Financial media is buzzing about the SpaceX IPO. Here's why I'm not buying in, and what I'm doing instead.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Forget the Fed: Why the Knicks Winning the NBA Finals Could Be the Biggest Downside Catalyst for the S&P 500

Just look at what happened the last time the New York Knicks won it all.

Iran War Apathy Has Left Rare Earth Stocks in Critical Condition. Stay Far Away from the REMX ETF’s Dangerous Trap.

Apparently there is such a thing as war apathy. Because for more than a month, investors have had it.

When Investors Finally Get Sick of AI Stocks, This Medical Devices ETF Could Be a Long-Term Winner

Over the long term, the IHI ETF looks like a good turnaround story.

Consumer Staples Stocks Are No Longer a Recession-Proof Haven Amid High Inflation. Just Look at the PBJ ETF.

In the old tactical playbook for a top-heavy, late-cycle market regime, one of the rules is “when growth gets risky, hide out in the consumer staples sector.” Well, the 20th century stock market called. And it wants its playbook back.

inkl

Read news from The Economist, FT, and more,
with one subscription

The Dow's Split Personality: Why Some Winners Soar While Others Drag Down the Dow

The Dow's Split Personality: Why Some Winners Soar While Others Drag Down the Dow

The oldest stock index in the world is suffering from a severe case of split personality. This internal friction has triggered a mechanical phenomenon, the likes of which I cannot recall, at least to this degree.

The VOO ETF Just Hit $1 Trillion in AUM. That’s a Terrifying Warning on ‘Terminal’ Index Concentration and the Risk of a $100 Million Loss.

The VOO ETF Just Hit $1 Trillion in AUM. That’s a Terrifying Warning on ‘Terminal’ Index Concentration and the Risk of a $100 Million Loss.

We have reached a new milestone in ETF trading. That is not necessarily a good thing.

Investors Are Fleeing to South Korean and Taiwan ETFs for Diversification. If You Do That, You’re Still Just Chasing AI Chip Stocks.

Investors Are Fleeing to South Korean and Taiwan ETFs for Diversification. If You Do That, You’re Still Just Chasing AI Chip Stocks.

Major tech companies like Taiwan Semi and Samsung dominate these single-country ETFs.

The SOXX ETF Recently Hit 10,000, but There's a Semiconductor Split Lurking Under the Hood

The SOXX ETF Recently Hit 10,000, but There's a Semiconductor Split Lurking Under the Hood

SOXX recently crossed the 10,000 mark for the first time. But at the same time, the underlying stocks in SOXX have an internal rift. Some semiconductor stocks have gone parabolic, while others are much flatter.

Lower Rates Are Helping Home Construction Stocks in the ITB ETF. I Think It’s Time to Move In.

Lower Rates Are Helping Home Construction Stocks in the ITB ETF. I Think It’s Time to Move In.

For the first time in modern housing history, the pricing gap between a newly manufactured home and a resale home has vanished.

Even If Eli Lilly Stock Continues to Shine, Stay Away from This Pharmaceutical ETF

Even If Eli Lilly Stock Continues to Shine, Stay Away from This Pharmaceutical ETF

The rest of the stocks in the IHE ETF make it an unappealing way to play the pharma industry here.

These New 0DTE Covered Call ETFs Are Not Magic Money Trees. In Fact, You’re Better Off Just Buying SPY.

These New 0DTE Covered Call ETFs Are Not Magic Money Trees. In Fact, You’re Better Off Just Buying SPY.

It is easy to say you’ll be OK with a fund handing you a nice yield while the price declines net out to a 20%-30% loss. But when it actually happens? The reality often produces a different reaction.

Get all your
news in one place.

100's of premium titles.
One news app.

Cracks Are Forming in Private Credit. The BIZD ETF Is Waving a Red Flag About Where This Market Is Going Next.

The upcoming trio of IPOs from SpaceX, OpenAI, and Anthropic could mark the end of this bullish private credit market cycle.

We Now Know for Sure That the Software Apocalypse Selloff Was Overdone. Buy Cloud and Software Stocks Now to Profit.

Infrastructure software names have been left behind amid a major AI rally.

Invest Like Warren Buffett and Buy Wide-Moat Stocks Via This ETF Ahead of a Major Market Shift

With index concentration at an all-time high, the stage is perfectly set for this ETF to make a solid comeback.

How Overzealous Option Traders Are Making 3X Leveraged ETFs Look Like Saviors

Warning: A key part of the options market you may be relying on is no longer working.

Get all your
news in one place.

100's of premium titles.
One news app.

The SpaceX IPO Is a Bet That Retail Investors Love Elon Musk So Much They’ll Fund His Money-Losing Empire

The SpaceX IPO is an optical illusion hiding in plain sight.

Wall Street Wants You to Chase the SpaceX, Anthropic, and OpenAI IPO Hype. History Tells Us That’s a Dangerous Game.

Rushing to own the latest “hot” stock can make you a financial victim in just a matter of days… or even hours.

A ‘Golden Dome’ Has Formed on the Chart of This Gold Mining ETF. The Bull Rally in Precious Metals Has Run Out of Steam.

The best days of the gold trade are firmly in the rearview mirror.

The S&P 500’s Price Is Getting Better Every Week, But This Indicator Keeps Getting Worse. Why 52% Could Be The Market’s Tragic Number.

Right now, the top 25 largest stocks in the S&P 500 account for a staggering 52% of the total index weight.

Nvidia and Micron Stocks Are Almost Exclusively Driving S&P Earnings Strength. These 3 Very Real Risks Could End It All.

Goldman Sachs data shows that together, Micron and Nvidia are responsible for one-third of all S&P 500 earnings growth in 2026.

The Ghosts of 1987 Appear: Kevin Warsh, Alan Greenspan, and How to Invest Safely Under a New Fed Chair

When a new Fed chair takes office at the White House amidst rising inflation, a bleeding bond market, and a speculative stock mania, the ghosts of 1987 aren’t just a curiosity. They are spirits to fear.

Don’t Ignore Basic Bond Math and Jump Into TIPS: The ‘Inflation Hedge’ Story Isn’t Everything

With sticky inflation re-emerging as the dominant macro story, retail investors are aggressively searching for a shield to protect their purchasing power.

1 2 3 4 5

People

195,023 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

the New York Knicks

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

383,868 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play